DT
PT
Subscribe To Print Edition About The Tribune Code Of Ethics Download App Advertise with us Classifieds
search-icon-img
search-icon-img
Advertisement

Dr Reddy’s to acquire Wockhardt’s generics biz

  • fb
  • twitter
  • whatsapp
  • whatsapp
Advertisement

Hyderabad: Dr Reddy’s Laboratories Ltd has entered into a definitive agreement with Wockhardt Ltd to acquire select divisions of its branded generics business in India and a few other international territories, including Sri Lanka and Maldives for Rs 1,850 crore, the drug maker said on Wednesday. The business comprises a portfolio of 62 brands in multiple therapy areas which would transfer to Dr Reddy’s along with related sales and marketing teams and the manufacturing plant located in Baddi with all plant employees. PTI

Advertisement

Advertisement
Advertisement
Advertisement
tlbr_img1 Classifieds tlbr_img2 Videos tlbr_img3 Premium tlbr_img4 E-Paper tlbr_img5 Shorts